Boehringer Ingelheim has won accelerated FDA approval for its combination HIV drug Aptivus. Release
Sponsored by GenScript
Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio
GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.